Mindbloom is designed to get to the root of your issues, not just treat the symptoms.
Meet With Your Clinician
Every client is paired with a licensed Mindbloom clinician who will review your health history to ensure that ketamine therapy is right for you. (If you aren’t a fit, you will receive a full refund.)

Mindbloom pairs individuals with licensed clinicians who are trained to diagnose and treat anxiety, depression, and other mental health conditions. If one of the licensed clinicians, in their medical judgment, decides that ketamine is an appropriate treatment for an individual based on a clinical assessment, then the clinician may prescribe ketamine tablets that are compounded by pharmacies under Section 503A of the federal Food, Drug, and Cosmetic Act (FDCA). Drugs compounded under Section 503A do not require FDA approval, and as such the FDA has not determined that the compounded ketamine prescribed is safe and effective for anxiety, depression, or other mental health conditions. The use of ketamine for anxiety, depression, and many other mental health conditions, however, is supported by a body of scientific literature. (Data on file).
Ketamine is a Schedule III controlled substance. Other drugs containing ketamine, which (unlike compounded drugs) are subject to FDA’s approval requirements, have been FDA-approved as an intravenous or intramuscular injection solution for induction and maintenance of general anesthesia. However, those drugs have not been FDA-approved for anxiety, depression, or other mental health conditions, and they have not been FDA-approved in tablet form. The approved label is available here.
Ketamine may cause serious side effects, including but not limited to risks of: sedation; dissociation; psychiatric events or worsening of psychiatric disorders, including problems in people with schizophrenia, severe personality disorders, or other serious mental disorders; dependence, abuse and misuse; anxiety; increases in blood pressure or heart rate; respiratory depression (breathing becomes slower and shallower and the lungs fail to exchange carbon dioxide and oxygen efficiently); lower urinary tract and bladder symptoms, including frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size; altered sense of time; dry mouth; elevated intraocular or intracranial pressure; loss of appetite; confusion; nausea/vomiting; blurred vision; and slurred speech.
The FDA has advised that at-home administration of compounded ketamine may present additional risks because a health care provider is not available onsite to monitor for adverse outcomes resulting from sedation and dissociation.
Mindbloom’s protocols and guidance have been designed to minimize the likelihood of experiencing these side effects or other adverse effects, and should be followed carefully. Ketamine should only be taken as directed by the treating clinician.
Do not proceed with ketamine treatment if any of the following apply to you:
- Allergic to ketamine
- Symptoms of psychosis or mania
- Uncontrolled high blood pressure
- CHF or other serious heart problem
- Severe breathing problem
- History of elevated intraocular or intracranial pressure
- History of hyperthyroidism
- Other serious medical illness
- Pregnant, nursing, or trying to become pregnant
Ketamine has been found to cause moderate psychological dependency in some users.
- In rare cases, frequent, heavy users have reported increased frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size
- Ketamine may worsen problems in people with schizophrenia, severe personality disorders, or other serious mental disorders
- Users with a personal or family history of psychosis should be cautious using any psychoactive substance, including ketamine, and discuss potential risks with your clinician before proceeding with treatment
- The dissociative effects of ketamine may increase patient vulnerability and the risk of accidents
To promote positive outcomes and ensure safety, follow these ketamine treatment guidelines:
- Do not operate a vehicle (e.g., car, motorcycle, bicycle) or heavy machinery following treatment until you’ve had a full night of sleep
- Refrain from taking benzodiazepines or stimulants for 24 hours prior to treatment
- Continue to take antihypertensive medication as prescribed
- Do not take ketamine while hungover or with alcoholic beverages
- Refrain from consuming solid foods within 3 hours prior to treatment and liquids within 1 hour prior to treatment
- Ketamine treatment should never be conducted without a peer treatment monitor physically present
A peer-reviewed study of Mindbloom’s client treatment outcomes was published in the Journal of Affective Disorders in 2022, titled At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial. The FDA has not evaluated head-to-head trials comparing the safety of ketamine to other medications that are FDA-approved for the treatment of depression, anxiety, or other psychiatric disorders. Although some clients report that they had more success with ketamine than with FDA-approved therapies, these outcomes may not be typical.
For more information about the informed consent that clients review and sign prior to treatment, please visit mindbloom.com/informed-consent.

Receive Your Bloombox
After your consultation, we will deliver your Bloombox to your door. Your Bloombox contains everything you need to complete your ketamine treatment from home.

Prepare With Your Guide
Next, we will pair you with a Mindbloom guide who will help you confidently and safely administer your medicine. Our guides are trained in supporting ketamine therapy and have helped facilitate 300,000+ sessions.

Your First Session
After preparing your space, begin treatment by placing the ketamine tablet under your tongue. The medicine’s effects last about 1 hour, during which you will relax on a sofa or bed with an eye mask on.

Choose a program designed for your goals
Mindbloom’s new personalized programs, or “pathways”, will help you see results faster and help you take steps toward the life you deserve.
Choose a program designed for your goals
Mindbloom’s new personalized programs, or “pathways”, will help you see results faster and help you take steps toward the life you deserve.
Recovering from Failure and Rejection
with DR. GUY WINCH

OVERVIEW:
You’ll learn practical skills and take advantage of ketamine’s neuroplastic effects to better bounce back from rejection and failure.
FOCUS AREAS:
- Manage self-criticism
- Revive self-worth
- Deepen personal connections
- Find opportunity in adversity
Overcoming Anxiety

OVERVIEW:
Learn to manage, overcome, and work with your anxiety while building a strong foundation as you identify obstacles and turn them into opportunities.
FOCUS AREAS:
- Anxiety as signal
- Building an action plan
- Emotional health
- Inner intelligence
Beyond Depression

OVERVIEW:
This pathway will help you manage depressive symptoms and life experiences as they arise, and build a new life, with you in charge of your emotional states.
FOCUS AREAS:
- Self-worth
- Reconnecting with yourself
- Interconnectedness
- The experience of depression
Learning to Love Yourself

OVERVIEW:
The Learning to Love Yourself pathway helps you to focus on the relationship that you have with yourself, while cultivating a deeper sense of self-worth.
FOCUS AREAS:
- Self-worth
- Acts of self-love
- Self-authoring
- Becoming whole
Navigating Grief

OVERVIEW:
Navigating Grief will help gently guide you through the grieving process and find joy as you reconnect with yourself and others in a supportive way.
FOCUS AREAS:
- Self-care for grieving
- Avoiding thought spirals
- Finding meaning
- Reconnecting with joy
Rewiring Habits

OVERVIEW:
Through Rewiring Habits, you’ll shatter the cycle of negative habits and replace them with routines that will help you take back control of your life.
FOCUS AREAS:
- Creating a future vision
- Habit stacking and subtraction
- Breaking bad habits
- The power of good habits
Managing Emotions
.webp)
OVERVIEW:
Managing Emotions is a powerful pathway that will help you overcome overwhelming feelings and build lasting emotional resilience.
FOCUS AREAS:
- Hidden triggers
- Emotions and the body
- The value of emotions
- Thoughts and feelings
Going Deeper

OVERVIEW:
You’ll better understand the science of ketamine and neuroplasticity, and how you can use these changes to improve your mood and life.
FOCUS AREAS:
- T.L.O—Trust. Let go. Be Open.
- Mindfulness and meditation
- Ketamine and the brain
- Leveraging neuroplasticity
Explore Integration Circles
As a Mindbloom client, you have unlimited access to Integration Circles, support groups designed to help you get the most out of your therapy.

Meet the Team
Our team of professionals is here to support you every step of the way.

Mindbloom pairs individuals with licensed clinicians who are trained to diagnose and treat anxiety, depression, and other mental health conditions. If one of the licensed clinicians, in their medical judgment, decides that ketamine is an appropriate treatment for an individual based on a clinical assessment, then the clinician may prescribe ketamine tablets that are compounded by pharmacies under Section 503A of the federal Food, Drug, and Cosmetic Act (FDCA). Drugs compounded under Section 503A do not require FDA approval, and as such the FDA has not determined that the compounded ketamine prescribed is safe and effective for anxiety, depression, or other mental health conditions. The use of ketamine for anxiety, depression, and many other mental health conditions, however, is supported by a body of scientific literature. (Data on file).
Ketamine is a Schedule III controlled substance. Other drugs containing ketamine, which (unlike compounded drugs) are subject to FDA’s approval requirements, have been FDA-approved as an intravenous or intramuscular injection solution for induction and maintenance of general anesthesia. However, those drugs have not been FDA-approved for anxiety, depression, or other mental health conditions, and they have not been FDA-approved in tablet form. The approved label is available here.
Ketamine may cause serious side effects, including but not limited to risks of: sedation; dissociation; psychiatric events or worsening of psychiatric disorders, including problems in people with schizophrenia, severe personality disorders, or other serious mental disorders; dependence, abuse and misuse; anxiety; increases in blood pressure or heart rate; respiratory depression (breathing becomes slower and shallower and the lungs fail to exchange carbon dioxide and oxygen efficiently); lower urinary tract and bladder symptoms, including frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size; altered sense of time; dry mouth; elevated intraocular or intracranial pressure; loss of appetite; confusion; nausea/vomiting; blurred vision; and slurred speech.
The FDA has advised that at-home administration of compounded ketamine may present additional risks because a health care provider is not available onsite to monitor for adverse outcomes resulting from sedation and dissociation.
Mindbloom’s protocols and guidance have been designed to minimize the likelihood of experiencing these side effects or other adverse effects, and should be followed carefully. Ketamine should only be taken as directed by the treating clinician.
Do not proceed with ketamine treatment if any of the following apply to you:
- Allergic to ketamine
- Symptoms of psychosis or mania
- Uncontrolled high blood pressure
- CHF or other serious heart problem
- Severe breathing problem
- History of elevated intraocular or intracranial pressure
- History of hyperthyroidism
- Other serious medical illness
- Pregnant, nursing, or trying to become pregnant
Ketamine has been found to cause moderate psychological dependency in some users.
- In rare cases, frequent, heavy users have reported increased frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size
- Ketamine may worsen problems in people with schizophrenia, severe personality disorders, or other serious mental disorders
- Users with a personal or family history of psychosis should be cautious using any psychoactive substance, including ketamine, and discuss potential risks with your clinician before proceeding with treatment
- The dissociative effects of ketamine may increase patient vulnerability and the risk of accidents
To promote positive outcomes and ensure safety, follow these ketamine treatment guidelines:
- Do not operate a vehicle (e.g., car, motorcycle, bicycle) or heavy machinery following treatment until you’ve had a full night of sleep
- Refrain from taking benzodiazepines or stimulants for 24 hours prior to treatment
- Continue to take antihypertensive medication as prescribed
- Do not take ketamine while hungover or with alcoholic beverages
- Refrain from consuming solid foods within 3 hours prior to treatment and liquids within 1 hour prior to treatment
- Ketamine treatment should never be conducted without a peer treatment monitor physically present
A peer-reviewed study of Mindbloom’s client treatment outcomes was published in the Journal of Affective Disorders in 2022, titled At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial. The FDA has not evaluated head-to-head trials comparing the safety of ketamine to other medications that are FDA-approved for the treatment of depression, anxiety, or other psychiatric disorders. Although some clients report that they had more success with ketamine than with FDA-approved therapies, these outcomes may not be typical.
For more information about the informed consent that clients review and sign prior to treatment, please visit mindbloom.com/informed-consent.
Clinicians
Our clinicians are licensed medical professionals who review your health history and ensure ketamine therapy is the right course of treatment for you.






Guides
Our trained guides answer any questions you might have and support you through your treatment.
Try the App
The Mindbloom app is designed to help you get the most out of your treatment.

Mindbloom pairs individuals with licensed clinicians who are trained to diagnose and treat anxiety, depression, and other mental health conditions. If one of the licensed clinicians, in their medical judgment, decides that ketamine is an appropriate treatment for an individual based on a clinical assessment, then the clinician may prescribe ketamine tablets that are compounded by pharmacies under Section 503A of the federal Food, Drug, and Cosmetic Act (FDCA). Drugs compounded under Section 503A do not require FDA approval, and as such the FDA has not determined that the compounded ketamine prescribed is safe and effective for anxiety, depression, or other mental health conditions. The use of ketamine for anxiety, depression, and many other mental health conditions, however, is supported by a body of scientific literature. (Data on file).
Ketamine is a Schedule III controlled substance. Other drugs containing ketamine, which (unlike compounded drugs) are subject to FDA’s approval requirements, have been FDA-approved as an intravenous or intramuscular injection solution for induction and maintenance of general anesthesia. However, those drugs have not been FDA-approved for anxiety, depression, or other mental health conditions, and they have not been FDA-approved in tablet form. The approved label is available here.
Ketamine may cause serious side effects, including but not limited to risks of: sedation; dissociation; psychiatric events or worsening of psychiatric disorders, including problems in people with schizophrenia, severe personality disorders, or other serious mental disorders; dependence, abuse and misuse; anxiety; increases in blood pressure or heart rate; respiratory depression (breathing becomes slower and shallower and the lungs fail to exchange carbon dioxide and oxygen efficiently); lower urinary tract and bladder symptoms, including frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size; altered sense of time; dry mouth; elevated intraocular or intracranial pressure; loss of appetite; confusion; nausea/vomiting; blurred vision; and slurred speech.
The FDA has advised that at-home administration of compounded ketamine may present additional risks because a health care provider is not available onsite to monitor for adverse outcomes resulting from sedation and dissociation.
Mindbloom’s protocols and guidance have been designed to minimize the likelihood of experiencing these side effects or other adverse effects, and should be followed carefully. Ketamine should only be taken as directed by the treating clinician.
Do not proceed with ketamine treatment if any of the following apply to you:
- Allergic to ketamine
- Symptoms of psychosis or mania
- Uncontrolled high blood pressure
- CHF or other serious heart problem
- Severe breathing problem
- History of elevated intraocular or intracranial pressure
- History of hyperthyroidism
- Other serious medical illness
- Pregnant, nursing, or trying to become pregnant
Ketamine has been found to cause moderate psychological dependency in some users.
- In rare cases, frequent, heavy users have reported increased frequency of urination, urinary incontinence, pain urinating, passing blood in the urine, or reduced bladder size
- Ketamine may worsen problems in people with schizophrenia, severe personality disorders, or other serious mental disorders
- Users with a personal or family history of psychosis should be cautious using any psychoactive substance, including ketamine, and discuss potential risks with your clinician before proceeding with treatment
- The dissociative effects of ketamine may increase patient vulnerability and the risk of accidents
To promote positive outcomes and ensure safety, follow these ketamine treatment guidelines:
- Do not operate a vehicle (e.g., car, motorcycle, bicycle) or heavy machinery following treatment until you’ve had a full night of sleep
- Refrain from taking benzodiazepines or stimulants for 24 hours prior to treatment
- Continue to take antihypertensive medication as prescribed
- Do not take ketamine while hungover or with alcoholic beverages
- Refrain from consuming solid foods within 3 hours prior to treatment and liquids within 1 hour prior to treatment
- Ketamine treatment should never be conducted without a peer treatment monitor physically present
A peer-reviewed study of Mindbloom’s client treatment outcomes was published in the Journal of Affective Disorders in 2022, titled At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial. The FDA has not evaluated head-to-head trials comparing the safety of ketamine to other medications that are FDA-approved for the treatment of depression, anxiety, or other psychiatric disorders. Although some clients report that they had more success with ketamine than with FDA-approved therapies, these outcomes may not be typical.
For more information about the informed consent that clients review and sign prior to treatment, please visit mindbloom.com/informed-consent.
Specialized Programs
Everyone’s mental health challenges are unique. Your treatment options should be too. Choose from programs in anxiety, depression, grief, improving habits, and more.



Music Library
Our Music Library is designed by our licensed music therapists to unlock the full potential of your ketamine sessions.
Journal Prompts
Using a journal after your sessions is a powerful way to integrate your ketamine therapy experience into your daily life. Our Journal Prompts help you translate your insights into action.




Learning and Integration Library
Our clinically-approved Learning and Integration Library contains resources on topics from anxiety to self-love, to moving on from grief and trauma.